These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 24135831

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation.
    Ulimoen SR, Enger S, Carlson J, Platonov PG, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal K, Tveit A.
    Am J Cardiol; 2013 Jan 15; 111(2):225-30. PubMed ID: 23111138
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diltiazem reduces levels of NT-proBNP and improves symptoms compared with metoprolol in patients with permanent atrial fibrillation.
    Enge K, Tveit A, Enger S, Onarheim S, Pripp AH, Rønningen PS, Solberg MG, Byrkjeland R, Andresen K, Halsen A, Aulie HA, Steinsvik T, Hall C, Ulimoen SR.
    Eur Heart J Cardiovasc Pharmacother; 2024 Oct 04; 10(6):515-525. PubMed ID: 38702844
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Slowing down the heart rate in permanent atrial fibrillation.
    Ehrlich JR, Ovsyshcher E.
    Eur Heart J; 2014 Feb 04; 35(8):480-1. PubMed ID: 24258074
    [No Abstract] [Full Text] [Related]

  • 8. Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study.
    Koh KK, Song JH, Kwon KS, Park HB, Baik SH, Park YS, In HH, Moon TH, Park GS, Cho SK.
    Int J Cardiol; 1995 Nov 24; 52(2):167-74. PubMed ID: 8749878
    [Abstract] [Full Text] [Related]

  • 9. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
    Phillips BG, Gandhi AJ, Sanoski CA, Just VL, Bauman JL.
    Pharmacotherapy; 1997 Nov 24; 17(6):1238-45. PubMed ID: 9399606
    [Abstract] [Full Text] [Related]

  • 10. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.
    J Am Coll Cardiol; 2010 Apr 27; 55(17):1780-7. PubMed ID: 20413026
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Diltiazem versus metoprolol for rate control in atrial fibrillation with rapid ventricular response in the emergency department.
    Hines MC, Reed BN, Ivaturi V, Bontempo LJ, Bond MC, Hayes BD.
    Am J Health Syst Pharm; 2016 Dec 15; 73(24):2068-2076. PubMed ID: 27919874
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modulation of ventricular rate in permanent atrial fibrillation: randomized, crossover study of the effects of slow-release formulations of gallopamil, diltiazem, or verapamil.
    Botto GL, Bonini W, Broffoni T.
    Clin Cardiol; 1998 Nov 15; 21(11):837-40. PubMed ID: 9825197
    [Abstract] [Full Text] [Related]

  • 20. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
    Shelton RJ, Clark AL, Goode K, Rigby AS, Cleland JG.
    Eur Heart J; 2006 Oct 15; 27(19):2353-61. PubMed ID: 16952921
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.